郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.

期刊：PLoS neglected tropical diseases发表年份：2008作者：Ernest J Mui; Guy A Schiehser; Wilbur K Milhous; Honghue Hsu; Craig W Roberts; Michael Kirisits; Stephen Muench; David Rice; J P Dubey; Joseph W Fowble; Pradipsinh K Rathod; Sherry F Queener; Susan R Liu; David P Jacobus; Rima McLeod
阅读更多 →

药效评价1-[1-Hexyl-6-(methyloxy)-1H-indazol-3-yl]-2-methyl-1-propanone, a potent and highly selective small molecule blocker of the large-conductance voltage-gated and calcium-dependent K+ channel.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2008作者：Haoyu Zeng; Earl Gordon; Zuojun Lin; Irina M Lozinskaya; Robert N Willette; Xiaoping Xu
阅读更多 →

药效评价Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity.

期刊：Journal of pharmacological sciences发表年份：2008作者：Akira Kikuchi; Katsuyo Ohashi; Yutaka Sugie; Hiromi Sugimoto; Hirofumi Omura
阅读更多 →

药效评价Substrate-targeting gamma-secretase modulators.

期刊：Nature发表年份：2008作者：Thomas L Kukar; Thomas B Ladd; Maralyssa A Bann; Patrick C Fraering; Rajeshwar Narlawar; Ghulam M Maharvi; Brent Healy; Robert Chapman; Alfred T Welzel; Robert W Price; Brenda Moore; Vijayaraghavan Rangachari; Bernadette Cusack; Jason Eriksen; Karen
阅读更多 →